Conno Biopharmaceutical Co., Ltd.-B has submitted a listing application to the Hong Kong Stock Exchange, with SDIC Securities International as the sole sponsor.

2026-01-25

Conno Biopharmaceutical Co., Ltd.-B has submitted a listing application to the Hong Kong Stock Exchange, with SDIC Securities International as the sole sponsor.